MNMD
Price
$9.91
Change
-$0.04 (-0.40%)
Updated
Sep 24, 12:16 PM (EDT)
Capitalization
757.08M
49 days until earnings call
RXRX
Price
$5.07
Change
+$0.26 (+5.41%)
Updated
Sep 24, 12:27 PM (EDT)
Capitalization
2.1B
42 days until earnings call
Interact to see
Advertisement

MNMD vs RXRX

Header iconMNMD vs RXRX Comparison
Open Charts MNMD vs RXRXBanner chart's image
Mind Medicine (MindMed)
Price$9.91
Change-$0.04 (-0.40%)
Volume$1.86K
Capitalization757.08M
Recursion Pharmaceuticals
Price$5.07
Change+$0.26 (+5.41%)
Volume$13.54K
Capitalization2.1B
MNMD vs RXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNMD vs. RXRX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNMD is a Buy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (MNMD: $9.95 vs. RXRX: $4.81)
Brand notoriety: MNMD and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNMD: 207% vs. RXRX: 187%
Market capitalization -- MNMD: $757.08M vs. RXRX: $2.1B
MNMD [@Biotechnology] is valued at $757.08M. RXRX’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNMD’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • MNMD’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, MNMD is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNMD’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • MNMD’s TA Score: 6 bullish, 2 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MNMD is a better buy in the short-term than RXRX.

Price Growth

MNMD (@Biotechnology) experienced а +2.47% price change this week, while RXRX (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.35%. For the same industry, the average monthly price growth was +10.13%, and the average quarterly price growth was +53.94%.

Reported Earning Dates

MNMD is expected to report earnings on Nov 12, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.1B) has a higher market cap than MNMD($757M). MNMD YTD gains are higher at: 42.960 vs. RXRX (-28.846). MNMD has higher annual earnings (EBITDA): -110.19M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. MNMD (183M). MNMD has less debt than RXRX: MNMD (41.2M) vs RXRX (88.1M). RXRX has higher revenues than MNMD: RXRX (64.5M) vs MNMD (0).
MNMDRXRXMNMD / RXRX
Capitalization757M2.1B36%
EBITDA-110.19M-583.64M19%
Gain YTD42.960-28.846-149%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash183M525M35%
Total Debt41.2M88.1M47%
FUNDAMENTALS RATINGS
MNMD: Fundamental Ratings
MNMD
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MNMDRXRX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 6 days ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
MNMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRUKX17.010.03
+0.18%
MFS Blended Research Value Equity R2
TEQIX15.730.01
+0.06%
Franklin Mutual Quest A
DSMDX20.61-0.06
-0.29%
Driehaus Small/Mid Cap Growth
DGFAX34.19-0.12
-0.35%
Davis Global A
FKGRX150.58-1.27
-0.84%
Franklin Growth A

MNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNMD has been loosely correlated with OCUL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MNMD jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNMD
1D Price
Change %
MNMD100%
+4.30%
OCUL - MNMD
51%
Loosely correlated
+0.41%
ATAI - MNMD
50%
Loosely correlated
+14.96%
RXRX - MNMD
50%
Loosely correlated
-3.41%
EYPT - MNMD
49%
Loosely correlated
+0.22%
SYRE - MNMD
48%
Loosely correlated
+4.77%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-3.41%
CRSP - RXRX
68%
Closely correlated
-2.16%
ABSI - RXRX
63%
Loosely correlated
-3.35%
BEAM - RXRX
61%
Loosely correlated
-2.79%
ABCL - RXRX
58%
Loosely correlated
+1.45%
NTLA - RXRX
55%
Loosely correlated
-1.04%
More